In this episode, Prof. Shigeo Ohta and David Maršálek, founder of H2 Global Group, return to the beginning of their “hydrogen” journey. Ohta describes how his academic research gradually led him to the long-term study of molecular hydrogen and why he sees it as a meaningful direction for modern medicine.
Maršálek follows with his personal story — from a key meeting in the United States with his first hydrogen mentor, Prof. Dušan Miljkovič, which launched his many years of work with hydrogen, to building a broader ecosystem around research, development, and clinical validation. The discussion is moderated by Radek Erben, an experienced Czech moderator and lecturer.
The main theme of the conversation is the plan for the future: to move hydrogen from the area of an “interesting supplement” into serious, measurable, and properly regulated medical use worldwide.
They mention concrete steps, international collaboration between Czech and Japanese teams, and an emphasis on clinical data. A clinical study has just been launched in the Czech Republic aiming to demonstrate the safety of non-invasive inhalation of molecular hydrogen in patients with mild cognitive impairment (MCI), which may precede the development of Alzheimer’s dementia.
www.H2global.group
www.MolekularniVodik.cz
www.H2Vibe.cz
H2 Global Group
H2 Vibe Style
You can find the full podcast here:
https://www.youtube.com/watch?v=pUKZ57wSwFo